Meyer Handelman CO Astrazeneca PLC Transaction History

Meyer Handelman CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 25, 2022	SELL	$54.02 - $63.83 $564,509 - $667,023	-10,450 Closed	0 $0
Q2 2021 Aug 18, 2021	BUY	$48.42 - $60.18 $505,989 - $628,881	10,450 New	10,450 $625,000
Q4 2020 Feb 03, 2021	SELL	$48.52 - $58.02 $507,034 - $606,309	-10,450 Closed	0 $0
Q3 2020 Oct 28, 2020	BUY	$53.07 - $61.1 $554,581 - $638,495	10,450 New	10,450 $573,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $208B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Meyer Handelman CO, based on Form 13F filings with the SEC.

Stay updated on Meyer Handelman CO with notifications on news.